Ortin Global Balance Sheet Annual

BSE: 539287 | NSE: ORTINGLOBE | ISIN: INE749B01020 | Sector: Biotechnology & Drugs

11.84 +0.55 (4.87%)Updated : 16 May 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	2.34	0.26	0.60	0.18
Cashand Short Term Investments	2.34	0.26	0.60	0.18
Accounts Receivable- Trade Net	1.77	3.42	3.24	3.91
Total Receivables Net	1.77	3.42	3.24	3.91
Total Inventory	0.05	2.60	1.74	1.83
Other Current Assets Total	2.19	0.26	0.18	0.20
Total Current Assets	6.34	6.54	5.75	6.13
Property/ Plant/ Equipment Total- Net	0.01	14.39	14.64	14.81
Long Term Investments	0.23	0.27	0.00	0.00
Other Long Term Assets Total	0.07	-	-	0.00
Total Assets	6.66	21.20	20.70	21.27
Accounts Payable	0.08	1.55	0.79	1.34
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	0.00	3.48	4.42	5.50
Other Currentliabilities Total	1.96	1.95	2.41	1.05
Total Current Liabilities	2.04	6.98	7.61	7.89
Long Term Debt	1.80	2.96	1.71	1.40
Capital Lease Obligations	0.00	0.00	0.02	0.05
Total Long Term Debt	1.80	2.96	1.73	1.44
Total Debt	1.80	6.45	6.14	6.94
Deferred Income Tax	0.00	0.25	0.27	0.40
Other Liabilities Total	0.00	0.14	0.14	0.18
Total Liabilities	3.84	10.33	9.75	9.91
Common Stock Total	8.13	8.13	8.13	8.13
Retained Earnings( Accumulated Deficit)	-5.31	2.73	2.83	3.22
Total Equity	2.82	10.86	10.96	11.36
Total Liabilities Shareholders' Equity	6.66	21.20	20.70	21.27
Total Common Shares Outstanding	0.81	0.81	0.81	0.81
Tangible Book Valueper Share Common Eq	3.47	13.36	13.47	13.97
period Length	0.00	0.00	0.00	0.00
Note Receivable- Long Term	-	-	0.32	0.33
Short Term Investments	-	-	-	0.00